Merck Annual Report 2010 by qLq9rW

VIEWS: 11 PAGES: 1

									Merck Annual Report 2010
Key figures for 2010

                                                                                             Corporate and
EUR million                                                   Pharmaceuticals   Chemicals            Other      Total    Change in %
Total revenues                                                        6,225.5     3,065.1                 –   9,290.6           19.9
Gross margin                                                          5,109.7     1,795.5                 –   6,905.2           20.8
Research and development                                              1,192.0       205.1                 –   1,397.1             3.9
Operating result                                                        579.0       624.0             -89.5   1,113.5           71.6
Exceptional items                                                        68.6        -1.0             -68.4      -0.8          -97.3
Earnings before interest and tax (EBIT)                                 647.6       623.0           -157.9    1,112.7           79.2
EBIT before depreciation and amortization (EBITDA)                    1,603.7     1,007.5           -154.3    2,456.9           51.2

Return on sales in % (ROS: operating result/total revenues)               9.3         20.4                –       12.0
Free cash flow                                                        1,343.6     -4,129.7           -736.4   -3,522.5             –
Underlying free cash flow                                             1,353.3        812.2           -495.7    1,669.8          96.1

								
To top